BOK Financial (NASDAQ:BOKF) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate of $1.43 by 37.06 percent. This is a 18.33 percent decrease over earnings of $2.40 per share from the same period last year.
Takeda Pharmaceutical’s Stock Ticks Higher as Q1 Sales Almost Flat At Constant Currency; Expects Headwinds For Rest Of 2023
Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Q1 FY23 net profit rose 4.1% (+0.9% at CER) to ¥233.4 billion, driven by
